New stock news | Giantec Semiconductor Corporation (688123.SH) submits documents to the Hong Kong Stock Exchange
According to the disclosure on January 26 by the Hong Kong Stock Exchange, Juchen Semiconductor Limited has submitted its application for listing on the main board of the Hong Kong Stock Exchange, with China International Capital Corporation Limited as the exclusive sponsor.
According to the disclosure by the Hong Kong Stock Exchange on January 26th, Giantec Semiconductor Corporation (688123.SH) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with CICC as the exclusive sponsor.
The prospectus shows that Giantec Semiconductor Corporation is a leading global high-performance non-volatile memory (NVM) chip design company, dedicated to meeting the storage needs of the high-speed iteration and expansion in the era of artificial intelligence. The company develops and supplies key storage chips such as SPD chips, EEPROMs, and NORFlash, mixed-signal chips such as camera motor drive chips, as well as NFC chips and supporting solutions. According to Frost & Sullivan, in 2023 and 2024, based on revenue, the company is the number one supplier of EEPROMs in China and the second-largest supplier of DDR5 SPD chips globally.
Related Articles

Qidian Guofeng (01280) reaches a GPU distribution cooperation agreement with Muxi Technology, entering the domestic AI computing power market.

Huishan Technology's IPO on the Shenzhen Stock Exchange has been temporarily suspended. In 2022-2024, their ice-making machine products ranked first in the domestic market share.

CF PHARMTECH (02652) spent 382,900 Hong Kong dollars to repurchase 11,000 shares on January 26th.
Qidian Guofeng (01280) reaches a GPU distribution cooperation agreement with Muxi Technology, entering the domestic AI computing power market.

Huishan Technology's IPO on the Shenzhen Stock Exchange has been temporarily suspended. In 2022-2024, their ice-making machine products ranked first in the domestic market share.

CF PHARMTECH (02652) spent 382,900 Hong Kong dollars to repurchase 11,000 shares on January 26th.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


